Rexahn Pharmaceuticals streamlines operations
Rexahn announced an operational restructuring that will enable a more efficient development of its clinical-stage oncology pipeline. Rexahn is lowering its operating costs including eliminating six positions, reducing the company’s workforce to 10. December 06, 2018